Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women
- 1 May 1991
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 55 (5) , 900-905
- https://doi.org/10.1016/s0015-0282(16)54296-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interval bone mineral density with long-term gonadotropin-releasing hormone agonist suppressionFertility and Sterility, 1989
- Vaginal hemorrhage associated with degenerating submucous leiomyomata during leuprolide acetate treatmentFertility and Sterility, 1989
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomataFertility and Sterility, 1989
- Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormoneFertility and Sterility, 1987
- Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile womenFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Leiomyomas: Steroid receptor contentAmerican Journal of Obstetrics and Gynecology, 1982
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981